financetom
TKNO
financetom
/
Healthcare
/
TKNO
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Alpha Teknova, Inc.TKNO
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
286.42M
Revenue (ttm)
37.75M
Net Income (ttm)
-26.75M
Shares Out
53.44M
EPS (ttm)
-0.57
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
113,243
Open
5.42
Previous Close
5.41
Day's Range
5.16 - 5.40
52-Week Range
1.16 - 10.37
Beta
0.55
Analysts
Buy
Price Target
5.00 (-6.72%)
Earnings Date
May 12, 2025
Description >

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics.

The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions.

The company was founded in 1996 and is headquartered in Hollister, California.

Copyright 2023-2025 - www.financetom.com All Rights Reserved